JASON VAN PELT

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies. S.3832/H.R.7142, Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Biopharmaceutical innovation and patent policy issues. Bayh-Dole march-in rights policy issues.

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Drug Pricing; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; CMMI Proposed Accelerated Approval Payment Policy; CMMI Medicaid Proposed Rebate Rule.

Issues related to federal health programs and prescription drugs; H.R.9027/S.4690, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.

Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, mental health, opioid abuse, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, plasma therapy, and step therapy; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; H.R.830, HELP Copays Act; S.127, Pharmacy Benefit Manager Transparency Act of 2023; H.R.3285, Fairness for Patient Medications Act; S.1339, Pharmacy Benefit Manager Reform Act; H.R.5378, Lower Costs, More Transparency Act; S.3430, Better Mental Health Care Lower-Cost Drugs and Health Extenders Act; S.2973, Modernizing and Ensuring PBM Accountability Act; H.R.6283, DRUG Act; H.R.2630, Safe Step Act.

TAKEDA PHARMACEUTICALS AMERICA, INC.

VERTEX PHARMACEUTICALS INCORPORATED

INDIVIOR INC.

LIFESCIENCE LOGISTICS

HALEON US HOLDINGS LLC

MARIUS PHARMACEUTICALS

MERCK & CO., INC.

HONE HEALTH

EISAI, INC.

TRANSAMERICA COMPANIES

NOVAVAX, INC.

THE BOEING COMPANY